URL: http://www.foodrisk.org/IRAC/events/2003-09-30/presentations/index.cfm
Symposium: Peer Review of Risk Assessments and Related Activities - Presentations
JOINT JIFSAN/SRA/RAC SYMPOSIUM
USDA/APHIS
4700 River Road
Riverdale, MD 20737
Conference Center Rooms C&D
September 30, 2003
Summary
of the meeting 
| 8:00 – 8:30 am |
Registration | |
| 8:30 – 8:40 am | Introductory Remarks |
Robert Buchanan, FDA/CFSAN |
| 8:40 – 8:50 am | Welcome | Elizabeth Calvey, FDA/CFSAN/JIFSAN |
Morning Session: Peer review of Risk Assessments and Related Activities: what it is, what it can do, and what are some pitfalls?
Moderator: Janell Kause, FSIS/USDA
| 8:50 – 9:15 am | Introduction: What is peer review? abstract  presentation  |
Heather Douglas, U. Puget Sound |
| 9:15 – 9:40 am | OIRA guidance on information quality and peer review |
Margo Schwab, OIRA |
| 9:40 – 10:05 am | Peer review – challenges raised by OMB's guidelines abstract presentation OMB Press Release |
Leslie Hushka, ExxonMobil Biomedical Sciences |
10:05 – 10:25 am |
BREAK |
|
| 10:25 – 10:50 am | Strengths and limitations of regulatory peer review abstract presentation |
Heather Douglas, U. Puget Sound |
| 10:50 – 11:15 am | Developing EPA's peer review program abstract presentation |
Dorothy Patton, Consultant (formerly EPA) |
| 11:15 – 11:40 am | Evolution of EPA’s peer review program abstract presentation |
Jeff Morris, EPA/ORD |
| 11:40 – 12:00 noon | Questions and answers period | |
12:00 – 1:00 pm |
LUNCH |
|
Afternoon Session: A. Peer review needs of FDA/CFSAN, FDA/CVM and USDA/FSIS
Moderator: Mary Bartholomew, FDA/CVM
| 1:00 – 1:25 pm | Federal review of risk assessments abstract presentation |
Jim Schaub, USDA/ORACBA |
| 1: 25 –1:50 pm | CFSAN’s needs for peer review of risk
assessments abstract presentation |
Robert Buchanan, FDA/CFSAN |
| 1:50 – 2:15 pm | USDA/FSIS' needs for peer review of
risk assessments abstract presentation |
Carol Maczka, USDA/FSIS |
| 2:15 – 2:40 pm | The role of the RAC in the peer review of
CVM’s risk assessments abstract presentation |
Barry Hooberman, FDA/CVM |
| 2:40 – 3:05 pm | The economic benefits of economic peer review abstract presentation |
Richard Williams, FDA/CFSAN |
| 3:05 – 3:30 pm | Questions and answers period | |
3:30 – 3:45 pm |
BREAK |
|
Afternoon Session: B. Panel Discussion and Closing Comments
Moderator: Mohamed Modarres, U. Maryland
| 3:45 - 4:45 pm | Panel discussiona | Panel membersb |
| 4:45 - 5:00 pm | Wrap-up and closing comments presentation |
Don Schaffner, Rutgers U. |
aPossible questions to be addressed by the
panel members and discussed include:
- What does ‘peer’ review really mean in a practical
sense?
- What are the key components of a peer review process?
- What value does peer review of risk assessments provide to
different organizations?
- How should peer review be conducted? Who should participate?
What work products should be subjected to peer review?
- How should different organizations respond to the results of a peer review?
bPanel members:
Robert Buchanan, FDA/CFSAN
Phil Deshong, U. Maryland
Leslie Hushka, ExxonMobil
Dorothy Patton, Consultant (formerly EPA)
Caroline Smith DeWaal, Consumer Science in the Public Interest
Carol Maczka, USDA/FSIS
